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This study explored the mechanisms of toxicity of microcystins by measuring the tran-
scription levels of nine cytoskeletal genes (actin, tubulin, vimentin, ezrin, radixin, moesin,
MAP1b, tau, stathmin) in the liver, kidney and spleen of male Wistar rats treated with
microcystins at a dose of 80 mgMC-LReq kg1 bw.Microcystins disrupted the transcriptional
homeostasis of cytoskeletal genes in these organs. Changes in the transcription of four genes
(b-actin, ezrin, radixin and tau) in liver, one gene (stathmin) in kidney, and one gene (radixin)
in spleen were signiﬁcantly correlated with the tissue concentration of microcystins.
However, the inﬂuences on the transcription of most genes we studied were greater in the
liver than in the kidney or spleen. The effects of microcystins on the transcription of cyto-
skeletal genesmay explain some of themorphological and pathological changes observed in
these organs and provide new information on the hepatotoxicity of these compounds.
Additionally, transcriptional changes in tumor-associated cytoskeletal genes (ezrin, moesin
and stathmin) that were observed in the present study provide a possible clue to the tumor-
promoting potential of microcystins and their inﬂuences on the transcription of MAP1b and
tau imply possible neurological toxicity of microcystins in vertebrates.
 2010 Published by Elsevier Ltd.1. Introduction
Cyanobacterial blooms are mostly dominated by
Microcystis species, which are well-studied producers of
a group of hepatotoxins known as microcystins. Micro-
cystins can cause lethal poisoning of ﬁsh, wildlife, livestock
and pets (Carmichael and Falconer, 1993; Dawson, 1998).
Human illnesses attributed to cyanobacterial toxins to date
may be categorized as: gastroenteritis and related diseases,
allergic and irritation reactions, and liver diseases (Bell and
Codd, 1994; Chorus et al., 2000; Hitzfeld et al., 2000). In
a recent study, microcystins were found to be transferred
from contaminated lake water and aquatic animals to2.
y Elsevier Ltd.a chronically exposed human population (ﬁshermen at
Lake Chaohu, China) (Chen et al., 2009).
Microcystins (MCs) comprise a family of more than 80
structurally related toxins. The most common are MC-LR,
MC-RR and MC-YR (Svrcek and Smith, 2004). These cyclic
heptapeptides preferentially accumulate in vertebrate liver
cells due to the presence of organic anion transporting
proteins (OATPs) that are highly expressed in this organ
(Fischer et al., 2005). However, accumulation of micro-
cystins has also been reported in the intestine, kidney,
spleen, gonad, heart, and muscles of ﬁsh and mammals
(Cazenave et al., 2005; Kagalou et al., 2008; Kankaanpa¨a¨
et al., 2005; Qiu et al., 2009). Recently, several researchers
have observed the accumulation of microcystins in the
brains of ﬁsh andmammals (Cazenave et al., 2005; Falconer
et al., 1986; Lei et al., 2008a,b; Wang et al., 2008) and
abnormal behavior associated with brain damage, suspected
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et al., 2004; Cazenave et al., 2008; Ernst et al., 2006).
The toxicity of microcystins has been attributed to the
highly speciﬁc inhibition of the phosphatases PP1 and PP2A
(Honkanen et al., 1990; MacKintosh et al., 1990), which in
turn leads to an increase in protein phosphorylation.
Accumulating evidence also implies that MC-dependent
damage in mammals is accompanied by oxidative stress
in the liver, kidney and intestinal mucosa (Botha et al.,
2004; Ding et al., 1998, 2001; Moreno et al., 2003, 2005).
It has been suggested that either of the above mechanisms
could induce cytoskeletal damage leading tomorphological
or pathological changes (Ding et al., 2001; Hooser et al.,
1991; Toivola et al., 1997).
The cytoskeleton consists of three major structural
elements: microﬁlaments (MFs), intermediate ﬁlaments
(IFs) and microtubules (MTs). MFs and MTs form highly
dynamic cytoskeletal networks composed, respectively, of
actin and tubulin polymers, and a large number of associ-
ated proteins (Andersen, 2000; Louvet-Valle´e, 2000). The
ERM family (ezrin, radixin and moesin) and stathmin,
which are proteins associated with MFs and MTs, respec-
tively, are involved in the promotion of malignant tumors
and metastases, including astrocytomas, uveal melanomas,
ovarian carcinoma, leukemia, lymphoma and neuroblas-
toma (Geiger et al., 2000; Ma¨kitie et al., 2001; Moilanen
et al., 2003; Rana et al., 2008). MAP1b and tau, which play
important roles in the neurological disorder Alzheimer’s
disease (AD), are classiﬁed as MT-associated proteins
(Alonso et al., 1994; Hasegawa et al., 1990).
In recent decades, morphological changes induced by
microcystins, and by cyanobacterium extracts have been
described in MFs, MTs and IFs. Hyperphosphorylation of
keratins 8 and 18 was stimulated by MC-LR in vivo and in
vitro, eventually leading to the disruption of the IFs (Toivola
et al., 1997, 1998). Several researchers have observed that
MC-LR-induced changes in ﬁbroblasts, kidney cells, and
some hepatocytes, ﬁrst occurred in IFs, followed byMTs, and
later MFs (Khan et al., 1996; Wickstrom et al., 1995). Ding
et al. (2001) observed that MC-LR induced changes in MFs
andMTs in primary rat hepatocytes and they suggested that
the binding of MC-LR to the cysteine residues of tubulin
subunits resulted in an increase in the quantity of free
tubulin, thereby reducing the stability of the tubulin mRNA
and decreasing the quantity of cellular tubulin. Clark et al.
(2007) studied transcriptional changes using a microarray
fromthe liverofmice exposed to aprolonged sub-lethal dose
of microcystin. Changes in the expression of many cyto-
skeletal genes were detected. Recently, protein expression
changes also have been detected by 2D gel electrophoresis.
For example, changes in the expression of several cytoskel-
etal proteins were reported in medaka ﬁsh (Oryzias latipes)
exposed to MC-LR at relatively high doses (Mezhoud et al.,
2008a,b) and changes have also been observed in human
amniotic epithelial FL cells (Fu et al., 2009). However, there
has been little focus on quantitative changes of cytoskeletal
gene expression and almost nothing is known about
MC-induced changes of MT-associated proteins and
MF-associated proteins.
To reveal the mechanisms underlying cytoskeletal
alterations stimulated by microcystins, we intravenouslyinjected rats with microcystin extracts and investigated
the transcription of three cytoskeletal proteins, three
MF-associated proteins and three MT-associated proteins
in liver, kidney and spleen.2. Materials and methods
2.1. Toxin
The cyanobacteria (mainly composed of Microcystis
spp. Microcystis aeruginosa) used in the experiment was
collected from Lake Dianchi, Yunnan Province of China.
Crude microcystins in the cyanobacteria were extracted
three times with 75% (V/V) methanol and suspended in
distilled water for the toxic experiment. Prior to use, the
material was analyzed for toxin content via reverse-phase
High Performance Liquid Chromatography (HPLC, LC-20A,
Shimadzu Corporation, Nakagyo-ku, Kyoto, Japan) equip-
pedwith anODS column (Cosmosil 5C18-AR, 4.6  150 mm,
Nacalai, Japan) and an SPA-10A UV–vis spectrophotometer
set at 238 nm. MC concentrations were determined by
comparing the peak areas of the test samples with stan-
dards (MC-LR and MC-RR, Wako Pure Chemical Industries,
Japan). As is described by Gupta et al. (2003), the intraper-
itoneal (i.p.) medium lethal dose (LD50) in mice for MC-RR
and MC-YR is about 5-fold and 2.5-fold that of MC-LR,
respectively, and the coefﬁcients used to convert MC-RR
and MC-YR into the MC-LR equivalent (MC-LReq) were 0.2
and 0.4, respectively. In the present experiment, the MC
content was 80 mg MC-LReq/mL, where MC-RR and MC-LR
constituted 167.7 mg/mL and 47.0 mg/mL, respectively. Crude
microcystin extracts were ﬁnally suspended in physiolog-
ical saline solution (0.9% NaCl).
2.2. Experimental protocol
Healthy male Wistar rats weighing 200  20 g were
obtained from the Center for Disease Control of Hubei
Province, China. The rats were kept in stainless steel cages
at 20 C under a 12 h light–dark cycle, and given free access
to standard rodent pellet diet and water. All procedures
carried out on animals were approved by the Institutional
Animal Care and Use Committee, and were in accordance
with the National Institutes of Health Guide for the Care
and Use of Laboratory.
1 mL suspension of extracted solution of microcystins
in physiological saline solution was intravenously injected
in the tail of 60 rats at a dose of 80 mg MC-LReq kg1 bw.
In addition, 60 rats were intravenously injected with 1 mL
physiological saline solution as control.
Five rats were collected from each group at 1, 2, 4,12 and
24 h after injection for total RNA isolation samples. Each rat
was killed and the liver, kidney and spleen were quickly
removed, washed, minced, and stored frozen in liquid
nitrogen until RNA isolation.
2.3. Total RNA extraction and reverse transcription
Total RNA was isolated from 30 to 50 mg sections of rat
organs using Trizol reagent (Invitrogen, America). RNAwas
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suspended in 50 mL RNase-free water, and stored at 80 C.
Quantiﬁcation was done using Eppendorf Biophotometer
(Hamburg, Germany). Reverse transcriptionwas performed
with oligo(dT) primer using First Strand cDNA Synthesis Kit
(Fermentas, Lithuania).
2.4. Quantitative real-time PCR (Q-PCR)
Some mRNA sequences of rat (Rattus norvegicus) were
searched in GenBank, according to which, the primers used
in real-time PCR were designed. The speciﬁcation of each
pair of primers was conﬁrmed by randomly sequencing six
clones, and further conﬁrmed by the melting curve analysis
using real-time PCR. The ampliﬁcation efﬁciency of each
pair of primers was tested by constructing the corre-
sponding plasmid and only primers with similar ampliﬁ-
cation efﬁciencies were used in this experiment. The
housekeeping gene GAPDH was analyzed in samples, and
the level of it was stable in the present experiments.
Therefore GAPDH was used as the endogenous assay
control.
SYBR Green Q-PCR kit (Toyobo, Japan) was used as
the ﬂuorescent dye for real-time quantitative PCR on
a Chromo4 96-well reactor with optical caps (MJ Research,
Cambridge, MA). The reactions were performed in a 20 mL
volume mix containing 10 mL SYBR Green I mixture
(Toyobo, Japan), 1 mL primers, 1 mL cDNA and 7 mL DEPC-
treated water. The thermal cycling program was: 3 min
denaturation at 95 C; for ampliﬁcation and quantiﬁcation
45 cycles of 30 s at 95 C, 30 s at 61–69 C (the annealing
temperature varied depending on the gene speciﬁc
primers), 30 s at 72 C, 1 s at 76–81 C (plate read for
targeted gene, temperature varied depending on the gene
speciﬁc primers), 1 s at 78 C (plate read for GAPDH),
a 10 min extension at 72 C, and then a melt curve from 70
to 90 C with a heating rate of 0.3 C s1.
Real-time PCRs were performed in triplicate for each
cDNA sample, and data were analyzed with the Option
Monitor Software 2.03 Version (MJ Research, Cambridge,
MA). Transcription of the nine genes in the control
remained stable throughout the 24 h and showed negli-
gible inter-individual variations during the experiment. All
the primers used in the real-time PCR are listed in Table 1.
2.5. Statistical analysis
All values are expressed as mean  standard deviation
for each treatment group. Statistical analysis of differencesTable 1
Primer sequences (50–30) used in this study.
Forward
Tau GGACAGGAAATGACGAGAAGAAAG
Tubulin ACCTGACCGTAGCCGCCATT
Moesin CTGCGGGCTGATGCTATGG
Radixin AGTGAGGGCGTGACGAACC
Ezrin CTGACTTCGTGTTCTACGCTCCC
Vimentin CAGGCAAAGCAGGAGTCAAACG
Actin GACCTCTATGCCAACACAGTGCTGT
Stathmin GGAGGTGAAGATGAGCCCGAGGAC
MAP1b CGTTACGCAGCCCTCCCCTTATbetween treatment groups and control groups was done by
one-sample T-test. Correlation between transcriptional
level of each gene and the microcystin concentrations in
the different organs was done using Pearson’s correlation
analysis. Software used for statistical analysis in the present
study is the SPSS (Chicago, IL, USA) forWindows (Ver. 13.0).
Differences were considered signiﬁcant if p  0.05.
3. Results
3.1. Changes in the transcription of actin, tubulin and
vimentin
3.1.1. Liver
The transcription of b-actin in the liver was signiﬁcantly
positive when correlated with the concentrations of
microcystins (Figs. 1 and 2, and Table 2). In the ﬁrst 2 h after
exposure, the a-tubulin transcriptional level was similar to
the control, it was signiﬁcantly higher at 4 and 6 h, and was
signiﬁcantly lower at 12 and 24 h. Microcystins induced
a time-dependent increase of vimentin transcription,
which was at a minimum (0.58-fold) after 1 h and at
a maximum level at 24 h (7.56-fold).
3.1.2. Kidney
No signiﬁcant alteration was detected in the transcrip-
tion levels of the three genes in the kidney (Fig. 1) during
the ﬁrst hour following microcystin treatment of rats.
Signiﬁcant changes in the transcription of b-actin and
a-tubulin were observable at 2 h and the transcription of
vimentin had increased signiﬁcantly at 12 and 24 h.
3.1.3. Spleen
The transcription of b-actin in spleen tissue (Fig. 1) was
signiﬁcantly augmented by microcystins in the ﬁrst 2 h,
with a peak at 1 h, but it was depressed signiﬁcantly from
4 h onward. Transcription of a-tubulin in the spleen was
signiﬁcantly lower than controls throughout the entire
experiment. Vimentin transcription was depressed signiﬁ-
cantly at 1, 2, 6 and 24 h.
3.2. Changes in the transcription of ERM family
3.2.1. Liver
The transcription of ezrin was signiﬁcantly higher than
in controls from 2 to 24 h except for the 12 h measurement
(Fig. 3). The transcription of radixin was signiﬁcantly
depressed throughout the entire experiment except for
a small elevation at 2 h (1.16-fold). The transcriptionalReverse
CC GGGAGCGACTGCCAGGGGTT
CGGTGCTGTTGCCAATGAA
GCAGGGTCTTGTATTTGTCTCGTC
GAATCTGCCGCAGAGTCTTGTAC
CGGTTTCCAACTGTTGTCGC
GCCATCTTTACATTGAGCAGGTCC
CTAGAAGCATTTGCGGTGCACGATG
CAGGGTAGGTTTCACTCCATCCAGAC
GCCTTGCTTTCCATTCTTCCCTTC
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Fig. 1. Relative mRNA expressions of b-actin, a-tubulin and vimentin in liver,
kidney and spleen after an i.v. injection with 80 mg MC-LReq kg1 bw. The
signiﬁcance levels observed are p < 0.05 (*) and p < 0.01 (**). act: b-actin;
tub: a-tubulin; vim: vimentin.
Table 2
Results of Pearson’s correlated analysis.
RR LR Total
Liver Actin 0.874* 0.927** 0.930**
Tau 0.924** 0.828* 0.905*
Ezrin 0.844* 0.827* 0.852*
Radixin 0.828* 0.833* 0.848*
Kidney Stathmin 0.831* 0.554 0.786
Spleen Radixin 0.928** 0.676 0.917*
* Correlation is signiﬁcant at the 0.05 level (2-tailed).
** Correlation is signiﬁcant at the 0.01 level (2-tailed).
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with the concentrations of toxins (Figs. 2 and 3 and Table
2). Signiﬁcant changes of moesin transcriptional level
were detected at 6 h (3.5-fold), and thereafter.
3.2.2. Kidney
Changes in the transcription of ezrin and moesin were
detected from 6 h (Fig. 3). Ezrin transcription was signiﬁ-
cantly elevated from 6 to 12 h and recovered to the level of
the controls at 24 h. Moesin transcription was signiﬁcantly
inhibited from 6 to 24 h. The transcription of radixin wasliver
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Fig. 2. Microcystin contents in Wistar rat tissues after an i.v. injsigniﬁcantly elevated at 1 h, it was signiﬁcantly depressed
from 2 to 6 h, and it recovered thereafter.
3.2.3. Spleen
No signiﬁcant induction of the transcription of the three
ERM family genes was detected. In fact, minima for ezrin,
radixin and moesin occurred at 6 h, by factors of 0.13, 0.01
and 0.04 relative to controls, respectively. The change in
radixin transcription was signiﬁcantly correlated with the
tissue concentrations of microcystins (Figs. 2 and 3, and
Table 2).
3.3. Changes in the transcription of MAPs
3.3.1. Liver
Transcription of MAP1b was depressed signiﬁcantly in
the ﬁrst 2 h, with one third less of template abundance than
controls (Fig. 4). A signiﬁcantly increased level of tran-
scription of MAP1b was observed from 4 h onward with an
approximately 4-fold increase from 4 to 12 h and a greater
than 16-fold increase at 24 h. The transcription of tau was
signiﬁcantly depressed at all times except for 12 h and was
signiﬁcantly correlated with the tissue concentrations of
microcystins. The transcription level of stathmin increased
signiﬁcantly and time-dependently from 4 to 12 h with
a 102-fold peak at 12 h. At the end of the experiment (24 h),
the relative abundance of stathmin was still more than 60
times that of controls.
3.3.2. Kidney
The inﬂuence of microcystins on the transcription of
MAP1b was much lower in kidney tissue than in liver. A
signiﬁcant alteration of MAP1b in kidneywas only detected
at 24 h (Fig. 5). The transcription of tau was depressed
throughout the experiment and this depression was
signiﬁcant at 1, 2 and 24 h. In contrast to tau, the tran-
scription of stathminwas signiﬁcantly higher in the treatedidney
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Fig. 3. Relative mRNA expressions of ezrin, radixin and moesin transcripts in
liver, kidney and spleen after an i.v. injection with 80 mg MC-LReq kg1 bw.
The signiﬁcance levels observed are p < 0.05 (*) and p < 0.01 (**). Ezr: ezrin;
Rdx: radixin; Msn: moesin.
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transcriptional change in stathmin was signiﬁcantly
correlated with the tissue concentration of MC-LR (Figs. 2
and 5 and Table 2).
3.3.3. Spleen
Signiﬁcantly increased transcription of MAP1b was
detected at 1 and 6 h only (Fig. 5). As in the kidney, tran-
scription of tau signiﬁcantly decreased in the treated rats
relative to the controls at 2, 4 and 24 h. Transcription of
stathmin showed a time-dependent increase from 1 to 6 h,MAP1b
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Fig. 4. Relative mRNA expressions of MAP1b, tau and stathmin in liver of rats after a
are p < 0.05 (*) and p < 0.01 (**).it was signiﬁcantly lower in the treated rats than in the
controls at 12 h, and then recovered at 24 h.4. Discussion
Microcystins in recreational and drinking waters
represent a potential hazard to the health of human pop-
ulations. The cytoskeleton, a basic structural element of all
cell types, plays key roles in the maintenance of cell
architecture, adhesion, migration, differentiation, division,
and organelle transport. Data from this study clearly show
that microcystins could disrupt the transcriptional balance
of some cytoskeletal proteins in the liver, kidney, and
spleen of rats. Moreover, transcriptional modulation of four
genes (b-actin, ezrin, radixin and tau) in the liver, one gene
(stathmin) in the kidney and one gene (radixin) in the
spleen was signiﬁcantly correlated with the concentration
of microcystins in these organs. Microcystins induce
morphological and pathological injuries (Li et al., 2005,
2008; Liu et al., 2010; Milutinovic´ et al., 2006; Qiu et al.,
2007, 2009) through redistribution of microﬁlament (MF)
(Eriksson et al., 1989; Falconer and Yeung, 1992; Ghosh
et al., 1995; Hooser et al., 1991), intermediate ﬁlaments
(IF) (Falconer and Yeung, 1992) and microtubules (MT)
(Khan et al., 1996; Wickstrom et al., 1995), and our results
suggest potential molecular mechanisms underlying these
phenomena.
Actins are central elements in the MF system. They are
highly conserved eukaryotic proteins, which occur both in
monomeric (globular or G-actin) and polymerized (ﬁla-
mentous or F-actin) forms (Stossel, 1984). The relative
proportions of F- and G-actins are determined by the
concentration of monomeric actin protein (Papakonstanti
and Stournaras, 2008). Previous studies have observed MF
destruction induced by microcystins, as indicated by loss of
arrays of stress ﬁbers, shortening of MFs, and detachment
from the plasma membrane (Batista et al., 2003; Ding et al.,
2000, 2001; Ghosh et al., 1995; Wickstrom et al., 1995).
Each of these alterations could result from a change in
monomeric actin concentration, which could in turn
disrupt the transcriptional homeostasis of actin. In our
experiment, changed transcription of b-actin in three
organs was detected. Levels of transcription in the liver
were positively correlated with the tissue concentrations of
microcystins, suggesting that transcriptional changes
played a critical role in microcystin-induced MF destruc-
tion. Besides b-actin, transcriptional change of three otherTau
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Fig. 5. Relative mRNA expressions of MAP1b, tau and stathmin in kidney and spleen of rats after an i.v. injection with 80 mg MC-LReq kg1 bw. The signiﬁcance
levels observed are p < 0.05 (*) and p < 0.01 (**).
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with the concentration of microcystins in liver but only one
gene was correlated with microcystin concentrations in
kidney and spleen. Moreover, the inﬂuences of micro-
cystins on the transcription of most of the genes observed
in the present researchweremore pronounced in liver than
in kidney or spleen, which provides new evidence for the
hepatotoxicity of microcystins.
Ezrin, radixin and moesin (ERM family) involve in cell
adhesion (Sato et al., 1992). Takeuchi et al. (1994) observed
that the suppression of ERM expression leads to the
destruction of both cell–cell and cell–substrate adhesion in
thymoma cells andmouse epithelial cells. The similar effect
was observed in two colo-rectal cancer cell lines in which
the expression of ezrin was inhibited at both protein and
mRNA levels (Hiscox and Jiang,1999). Besides this function,
the sub-cellular redistribution of these proteins and the
expression levels of these genes are associated with
tumorigenesis as well as motility and invasive behavior of
malignant cells (Carmeci et al., 1998; Moilanen et al., 2003;
Tokunou et al., 2000). Ezrin is the most studied of these
three genes and its crucial role in tumor progression seems
reasonably certain (Zeng et al., 2006). Its abnormal
expression has been detected in many malignant tumors at
both transcription and protein levels (Elliott et al., 2005;
Geiger et al., 2000; Guan et al., 2002; Ilmonen et al.,
2005; Moilanen et al., 2003; Tokunou et al., 2000; Weng
et al., 2005; Zeng et al., 2006). Likewise, the higher
expression of moesin in the cell line with the more
malignant phenotype at both transcription and protein
levels was detected by Carmeci et al. (1998). In the present
study, transcription of two ERM family genes (ezrin and
radixin) was positively correlated with the concentration of
microcystins in the liver of treated rats and the transcrip-
tion of radixin was correlated with the concentration of
microcystins in both liver and kidney. In contrast, all
signiﬁcant changes in the transcription of these three genes
in the spleen were inhibitory. Many studies have shown
that inhibition of PP (Chen et al., 1995; Louvet-Valle´e, 2000;
Nakamura et al., 1995) and activation of calpain or in turn
increased concentrations of Ca2þ (Shcherbina et al., 1999;
Shuster and Herman, 1995; Yao et al., 1993) can all inﬂu-
ence the activity, expression, and even transcription of
these three genes. The effects of PP inhibition and calpain
activation could both be results of microcystin stimulation
(Ding et al., 2002; Honkanen et al., 1990; MacKintosh et al.,
1990). Therefore, we suggest that the explanation ofmicrocystin-induced cell adherence loss (Ding et al., 2000;
Khan et al., 1996; Li et al., 2004, 2005; Qiu et al., 2009;
Wickstrom et al., 1995) is the inﬂuence on the expression
of ERM family in mRNA or protein level. Meanwhile, our
observations also provide new insights into the potential
carcinogenesis of microcystins.
Stathmin, one type of microtubule-associated protein,
also known as oncoprotein 18 (op18), regulatesmicrotubule
dynamics by promoting depolymerization of MTs and/or
preventing polymerization of tubulin heterodimers
(Cassimeris, 2002; McNally, 1999). Its over-expression was
detected across a broad range of human malignancies
(leukemia, lymphoma, neuroblastoma; ovarian, prostatic,
breast and lung cancers and mesothelioma) and it is
up-regulated in normally proliferating cell lines (Rana et al.,
2008). Moreover, in lung adenocarcinoma, protein over-
expression is correlated with Affymetrix mRNA expression
(Chen et al., 2003). In the present study, the transcription of
stathmin was signiﬁcantly elevated in the liver and kidney
of microcystin-treated rats and transcriptional changes in
the kidney were signiﬁcantly correlated with the concen-
tration of MC-LR. Therefore, changed transcription of
stathmin induced by microcystins is another possible
mechanism of MC-mediated tumor-promotion.
Unlike stathmin, the major known biological functions
of MAP1b and tau are to promote assembly of microtubules
and to stabilize microtubules by binding to them. In our
research, the transcription of tauwas depressed throughout
the experiment and, in the liver, changes in the transcrip-
tion level were signiﬁcantly correlated with the concen-
tration of microcystins. The transcription of MAP1b was
signiﬁcantly elevated in liver 2 h after MC treatment and
after 24 h it wasmore than 15-fold higher than the controls.
These transcriptional changes could be caused by negative
feedback regulation from changed expression of the
protein. It is reported that after being treated with another
PP2A inhibitor, okadaic acid, protein expression of tau in rat
brain was signiﬁcantly increased, and expression of MAP1b
was reduced (Gong et al., 2000a,b). ThemajorMAPs present
in brain are phosphoproteins MAP1, MAP2 and tau
(Kirkpatrick and Brady, 1999). Phosphorylation alters their
interaction with microtubules (Alexa et al., 1996; Jameson
and Caplow, 1981; Pedrotti et al., 1996). Several studies
have observed abnormal phosphorylation of MAP1b and
tau in AD brain (Alonso et al., 1994; Hasegawa et al., 1990;
Iqbal et al., 1994; Ulloa et al., 1994; Wang et al., 1995,
1996). Correspondingly, a decreased activity of PP2A was
L. Hao et al. / Toxicon 55 (2010) 1378–13861384found in AD brains (Gong et al., 1993, 1995; Speciale et al.,
1995). As a potent inhibitor of PP2A, microcystins have
been shown to be able to cross through the blood–brain
barrier and accumulate in brains of both mammals and ﬁsh
(Cazenave et al., 2005; Falconer et al., 1986; Lei et al.,
2008a,b; Wang et al., 2008). Furthermore, in the Brazilian
hemodialysis event, patients developed predominantly
neurological symptoms shortly after dialysis, in some cases
within hours. Thus, change of MAPs (phosphorylation
modiﬁcation, protein expression or transcription) in brain
might provide an explanation for the abnormal behavior
of ﬁsh stimulated by microcystins (Baganz et al., 2004;
Cazenave et al., 2008; Ernst et al., 2006). Changes in the
transcription of MAP1b and tau that we demonstrated in
our research suggest a possible mechanism for neurological
toxicity of microcystins in vertebrates.
In conclusion, we showed that microcystins affected
the homeostasis of the transcription of nine cytoskeletal
genes (b-actin, a-tubulin, vimentin, ezrin, radixin, moesin,
tau, MAP1b and stathmin) in the liver, kidney and spleen
of rats injected intravenously with microcystins at a dose
of 80 mg MC-LReq kg1 bw. Our observations suggest that
the effects of microcystins on the transcriptional level of
these genes could be a factor leading to morphological
changes, abnormal behavior, and increased tumor-
promoting activity in mammals exposed to microcystins.
Transcriptional changes of MAP1b and tau shown in our
research provide evidence for the neurological toxicity of
microcystins in vertebrates. Due to the wide occurrence of
cyanobacterial blooms containing microcystins, and the
identiﬁcation of microcystins in the serum of a chronically
exposed human population (Chen et al., 2009), further
research should be directed to the potential tumorigenesis
and neurological toxicity of microcystins.
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